These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Rosenberg SA Immunity; 1999 Mar; 10(3):281-7. PubMed ID: 10204484 [No Abstract] [Full Text] [Related]
23. Immunotherapy strategies in multiple myeloma. Bae J; Munshi NC; Anderson KC Hematol Oncol Clin North Am; 2014 Oct; 28(5):927-43. PubMed ID: 25212890 [TBL] [Abstract][Full Text] [Related]
24. Introduction: Cancer Immunology Special Issue-Immunotherapy. Kawakami Y Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100 [No Abstract] [Full Text] [Related]
25. Regionalization and Its Alternatives. Lumpkin S; Stitzenberg K Surg Oncol Clin N Am; 2018 Oct; 27(4):685-704. PubMed ID: 30213413 [TBL] [Abstract][Full Text] [Related]
26. "Tumor immunology meets oncology" (TIMO) XI, May 22-23, 2015, Halle/Saale, Germany. Quandt D; Seliger B Cancer Immunol Immunother; 2016 May; 65(5):625-30. PubMed ID: 27060001 [No Abstract] [Full Text] [Related]
28. Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. Koido S; Homma S; Takahara A; Namiki Y; Komita H; Uchiyama K; Ito M; Gong J; Ohkusa T; Tajiri H Immunotherapy; 2012 Jan; 4(1):5-7. PubMed ID: 22149993 [No Abstract] [Full Text] [Related]
29. Booming cancer immunotherapy fighting tumors. Li D; Wang W Sci China Life Sci; 2017 Dec; 60(12):1445-1449. PubMed ID: 29170888 [No Abstract] [Full Text] [Related]
30. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism. Nelson B Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750 [No Abstract] [Full Text] [Related]
31. The Accountable Care Organization for Surgical Care. Resnick MJ Surg Oncol Clin N Am; 2018 Oct; 27(4):717-725. PubMed ID: 30213415 [TBL] [Abstract][Full Text] [Related]
32. MUC1 as a target antigen for cancer immunotherapy. Acres B; Limacher JM Expert Rev Vaccines; 2005 Aug; 4(4):493-502. PubMed ID: 16117706 [TBL] [Abstract][Full Text] [Related]
33. Immunotherapy as an Option for Cancer Treatment. Rusch T; Bayry J; Werner J; Shevchenko I; Bazhin AV Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):89-96. PubMed ID: 29026920 [TBL] [Abstract][Full Text] [Related]
34. Letter from the editor. Ellis R; Riedmann EM Hum Vaccin Immunother; 2014; 10(1):1-2. PubMed ID: 24832715 [No Abstract] [Full Text] [Related]
35. Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious disease. Leffers N; Daemen T; van der Zee AG; Nijman HW Immunotherapy; 2009 Mar; 1(2):163-5. PubMed ID: 20635935 [No Abstract] [Full Text] [Related]
36. Vaccine immunotherapy in lung cancer: Clinical experience and future directions. Freeman-Keller M; Goldman J; Gray J Pharmacol Ther; 2015 Sep; 153():1-9. PubMed ID: 25989231 [TBL] [Abstract][Full Text] [Related]
37. [New directions in immunotherapy for malignant solid tumors]. Okuno K; Sugiura F; Sukegawa Y; Inoue K Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377 [TBL] [Abstract][Full Text] [Related]
38. Cancer Care Delivery Research: A Path to Improving the Quality of Oncologic Surgical Care. Stankowski-Drengler TJ; Neuman HB Surg Oncol Clin N Am; 2018 Oct; 27(4):653-663. PubMed ID: 30213410 [TBL] [Abstract][Full Text] [Related]
39. What is new in pediatric surgical oncology? Dasgupta R; Billmire D; Aldrink JH; Meyers RL Curr Opin Pediatr; 2017 Feb; 29(1):3-11. PubMed ID: 27845967 [TBL] [Abstract][Full Text] [Related]
40. [Immunotherapy in surgical cancer patients]. Schackert HK; Betzler M; Herfarth C Chirurg; 1988 May; 59(5):317-22. PubMed ID: 3293943 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]